fibrinogen has been researched along with Mast Cell Activation Disease in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Castells, MC; Hansbro, PM; Prieto-GarcĂa, A; Stevens, RL | 1 |
Ghildyal, N; Gurish, MF; Huang, C; Matsumoto, R; Qiu, WT; Sali, A; Stevens, RL; Wong, GW | 1 |
1 review(s) available for fibrinogen and Mast Cell Activation Disease
Article | Year |
---|---|
Mast cell-restricted tetramer-forming tryptases and their beneficial roles in hemostasis and blood coagulation.
Topics: Anaphylaxis; Blood Coagulation; Fibrin; Fibrinogen; Gene Expression Regulation, Neoplastic; Histamine; Humans; Isoenzymes; Mast Cells; Mastocytosis; Protein Multimerization; Signal Transduction; Skin; Thrombin; Tryptases | 2014 |
1 other study(ies) available for fibrinogen and Mast Cell Activation Disease
Article | Year |
---|---|
The tryptase, mouse mast cell protease 7, exhibits anticoagulant activity in vivo and in vitro due to its ability to degrade fibrinogen in the presence of the diverse array of protease inhibitors in plasma.
Topics: Anaphylaxis; Animals; Anticoagulants; Blood Proteins; Chymases; Enzyme Activation; Fibrinogen; Hydrogen-Ion Concentration; Inflammation Mediators; Mastocytosis; Mice; Mutagenesis, Site-Directed; Protease Inhibitors; Rats; Recombinant Proteins; Serine Endopeptidases; Tryptases | 1997 |